Lymphedema after Sentinel lymph node biopsy for cutaneous melanoma: A report of 5 cases
Identifieur interne : 00A898 ( Main/Exploration ); précédent : 00A897; suivant : 00A899Lymphedema after Sentinel lymph node biopsy for cutaneous melanoma: A report of 5 cases
Auteurs : D. A. Wrone [États-Unis] ; K. K. Tanabe [États-Unis] ; A. B. Cosimi [États-Unis] ; M. A. Gadd [États-Unis] ; W. W. Souba [États-Unis] ; A. J. Sober [États-Unis]Source :
- Archives of dermatology : (1960) [ 0003-987X ] ; 2000.
Descripteurs français
- KwdFr :
- MESH :
- anatomopathologie : Mélanome, Noeuds lymphatiques, Tumeurs cutanées.
- diagnostic : Lymphoedème.
- effets indésirables : Biopsie.
- étiologie : Lymphoedème.
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
- Adenopathy, Adult, Biopsy, Biopsy (adverse effects), Complication, Female, Human, Humans, Lymph Nodes (pathology), Lymphedema, Lymphedema (diagnosis), Lymphedema (etiology), Male, Malignant melanoma, Melanoma (complications), Melanoma (pathology), Middle Aged, Skin, Skin Neoplasms (complications), Skin Neoplasms (pathology), Time Factors.
- MESH :
- adverse effects : Biopsy.
- complications : Melanoma, Skin Neoplasms.
- diagnosis : Lymphedema.
- etiology : Lymphedema.
- pathology : Lymph Nodes, Melanoma, Skin Neoplasms.
- Adult, Female, Humans, Male, Middle Aged, Time Factors.
Abstract
Background: Sentinel lymph node (SLN) biopsy has rapidly become the procedure of choice for assessing the lymph node status of patients with 1992 American Joint Committee on Cancer stages I and II melanoma. The procedure was designed to be less invasive and, therefore, less likely to cause complications than a complete lymph node dissection. To our knowledge, this is the first report in the literature documenting extremity lymphedema following SLN biopsy. Observation: We report 5 cases of lymphedema after SLN biopsy in patients being routinely followed up after melanoma surgery at the Massachusetts General Hospital Melanoma Center, Boston. Three cases were mild, and 2 were moderate. Potential contributing causes of lymphedema were present in 4 patients and included the transient formation of hematomas and seromas, obesity, the possibility of occult metastatic melanoma, and the proximal extremity location of the primary melanoma excision. Four of the patients underwent an SLN biopsy at our institution. We used the total number of SLN procedures (N = 235) that we have performed to calculate a 1.7% baseline incidence of lymphedema after SLN biopsy. Conclusions: Sentinel lymph node biopsy can be complicated by mild and moderate degrees of lymphedema, with an incidence of at least 1.7%. Some patients may have contributing causes for lymphedema other than the SLN biopsy, but many of these causes are difficult to modify or avoid.
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000931
- to stream PascalFrancis, to step Curation: 000029
- to stream PascalFrancis, to step Checkpoint: 000912
- to stream Main, to step Merge: 00AE43
- to stream PubMed, to step Corpus: 004A89
- to stream PubMed, to step Curation: 004A89
- to stream PubMed, to step Checkpoint: 004A89
- to stream Ncbi, to step Merge: 000314
- to stream Ncbi, to step Curation: 000314
- to stream Ncbi, to step Checkpoint: 000314
- to stream Main, to step Merge: 00A729
- to stream Main, to step Curation: 00A898
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Lymphedema after Sentinel lymph node biopsy for cutaneous melanoma: A report of 5 cases</title><author><name sortKey="Wrone, D A" sort="Wrone, D A" uniqKey="Wrone D" first="D. A." last="Wrone">D. A. Wrone</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Massachusetts General Hospital Melanoma Center</s1><s2>Boston</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Boston</settlement><region type="state">Massachusetts</region></placeName></affiliation><affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Department of Dermatology, Massachusetts General Hospital</s1><s2>Boston</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Boston</settlement><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Tanabe, K K" sort="Tanabe, K K" uniqKey="Tanabe K" first="K. K." last="Tanabe">K. K. Tanabe</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Massachusetts General Hospital Melanoma Center</s1><s2>Boston</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Boston</settlement><region type="state">Massachusetts</region></placeName></affiliation><affiliation wicri:level="3"><inist:fA14 i1="03"><s1>Department of Surgery, Massachusetts General Hospital</s1><s2>Boston</s2><s3>USA</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Boston</settlement><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Cosimi, A B" sort="Cosimi, A B" uniqKey="Cosimi A" first="A. B." last="Cosimi">A. B. Cosimi</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Massachusetts General Hospital Melanoma Center</s1><s2>Boston</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Boston</settlement><region type="state">Massachusetts</region></placeName></affiliation><affiliation wicri:level="3"><inist:fA14 i1="03"><s1>Department of Surgery, Massachusetts General Hospital</s1><s2>Boston</s2><s3>USA</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Boston</settlement><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Gadd, M A" sort="Gadd, M A" uniqKey="Gadd M" first="M. A." last="Gadd">M. A. Gadd</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Massachusetts General Hospital Melanoma Center</s1><s2>Boston</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Boston</settlement><region type="state">Massachusetts</region></placeName></affiliation><affiliation wicri:level="3"><inist:fA14 i1="03"><s1>Department of Surgery, Massachusetts General Hospital</s1><s2>Boston</s2><s3>USA</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Boston</settlement><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Souba, W W" sort="Souba, W W" uniqKey="Souba W" first="W. W." last="Souba">W. W. Souba</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Massachusetts General Hospital Melanoma Center</s1><s2>Boston</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Boston</settlement><region type="state">Massachusetts</region></placeName></affiliation><affiliation wicri:level="3"><inist:fA14 i1="03"><s1>Department of Surgery, Massachusetts General Hospital</s1><s2>Boston</s2><s3>USA</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Boston</settlement><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Sober, A J" sort="Sober, A J" uniqKey="Sober A" first="A. J." last="Sober">A. J. Sober</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Massachusetts General Hospital Melanoma Center</s1><s2>Boston</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Boston</settlement><region type="state">Massachusetts</region></placeName></affiliation><affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Department of Dermatology, Massachusetts General Hospital</s1><s2>Boston</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Boston</settlement><region type="state">Massachusetts</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">00-0323767</idno><date when="2000">2000</date><idno type="stanalyst">PASCAL 00-0323767 INIST</idno><idno type="RBID">Pascal:00-0323767</idno><idno type="wicri:Area/PascalFrancis/Corpus">000931</idno><idno type="wicri:Area/PascalFrancis/Curation">000029</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000912</idno><idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000912</idno><idno type="wicri:doubleKey">0003-987X:2000:Wrone D:lymphedema:after:sentinel</idno><idno type="wicri:Area/Main/Merge">00AE43</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:10768650</idno><idno type="wicri:Area/PubMed/Corpus">004A89</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004A89</idno><idno type="wicri:Area/PubMed/Curation">004A89</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">004A89</idno><idno type="wicri:Area/PubMed/Checkpoint">004A89</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">004A89</idno><idno type="wicri:Area/Ncbi/Merge">000314</idno><idno type="wicri:Area/Ncbi/Curation">000314</idno><idno type="wicri:Area/Ncbi/Checkpoint">000314</idno><idno type="wicri:doubleKey">0003-987X:2000:Wrone D:lymphedema:after:sentinel</idno><idno type="wicri:Area/Main/Merge">00A729</idno><idno type="wicri:Area/Main/Curation">00A898</idno><idno type="wicri:Area/Main/Exploration">00A898</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Lymphedema after Sentinel lymph node biopsy for cutaneous melanoma: A report of 5 cases</title><author><name sortKey="Wrone, D A" sort="Wrone, D A" uniqKey="Wrone D" first="D. A." last="Wrone">D. A. Wrone</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Massachusetts General Hospital Melanoma Center</s1><s2>Boston</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Boston</settlement><region type="state">Massachusetts</region></placeName></affiliation><affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Department of Dermatology, Massachusetts General Hospital</s1><s2>Boston</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Boston</settlement><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Tanabe, K K" sort="Tanabe, K K" uniqKey="Tanabe K" first="K. K." last="Tanabe">K. K. Tanabe</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Massachusetts General Hospital Melanoma Center</s1><s2>Boston</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Boston</settlement><region type="state">Massachusetts</region></placeName></affiliation><affiliation wicri:level="3"><inist:fA14 i1="03"><s1>Department of Surgery, Massachusetts General Hospital</s1><s2>Boston</s2><s3>USA</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Boston</settlement><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Cosimi, A B" sort="Cosimi, A B" uniqKey="Cosimi A" first="A. B." last="Cosimi">A. B. Cosimi</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Massachusetts General Hospital Melanoma Center</s1><s2>Boston</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Boston</settlement><region type="state">Massachusetts</region></placeName></affiliation><affiliation wicri:level="3"><inist:fA14 i1="03"><s1>Department of Surgery, Massachusetts General Hospital</s1><s2>Boston</s2><s3>USA</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Boston</settlement><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Gadd, M A" sort="Gadd, M A" uniqKey="Gadd M" first="M. A." last="Gadd">M. A. Gadd</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Massachusetts General Hospital Melanoma Center</s1><s2>Boston</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Boston</settlement><region type="state">Massachusetts</region></placeName></affiliation><affiliation wicri:level="3"><inist:fA14 i1="03"><s1>Department of Surgery, Massachusetts General Hospital</s1><s2>Boston</s2><s3>USA</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Boston</settlement><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Souba, W W" sort="Souba, W W" uniqKey="Souba W" first="W. W." last="Souba">W. W. Souba</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Massachusetts General Hospital Melanoma Center</s1><s2>Boston</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Boston</settlement><region type="state">Massachusetts</region></placeName></affiliation><affiliation wicri:level="3"><inist:fA14 i1="03"><s1>Department of Surgery, Massachusetts General Hospital</s1><s2>Boston</s2><s3>USA</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Boston</settlement><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Sober, A J" sort="Sober, A J" uniqKey="Sober A" first="A. J." last="Sober">A. J. Sober</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Massachusetts General Hospital Melanoma Center</s1><s2>Boston</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Boston</settlement><region type="state">Massachusetts</region></placeName></affiliation><affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Department of Dermatology, Massachusetts General Hospital</s1><s2>Boston</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Boston</settlement><region type="state">Massachusetts</region></placeName></affiliation></author></analytic><series><title level="j" type="main">Archives of dermatology : (1960)</title><title level="j" type="abbreviated">Arch. dermatol. : (1960)</title><idno type="ISSN">0003-987X</idno><imprint><date when="2000">2000</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Archives of dermatology : (1960)</title><title level="j" type="abbreviated">Arch. dermatol. : (1960)</title><idno type="ISSN">0003-987X</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adenopathy</term><term>Adult</term><term>Biopsy</term><term>Biopsy (adverse effects)</term><term>Complication</term><term>Female</term><term>Human</term><term>Humans</term><term>Lymph Nodes (pathology)</term><term>Lymphedema</term><term>Lymphedema (diagnosis)</term><term>Lymphedema (etiology)</term><term>Male</term><term>Malignant melanoma</term><term>Melanoma (complications)</term><term>Melanoma (pathology)</term><term>Middle Aged</term><term>Skin</term><term>Skin Neoplasms (complications)</term><term>Skin Neoplasms (pathology)</term><term>Time Factors</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Biopsie (effets indésirables)</term><term>Facteurs temps</term><term>Femelle</term><term>Humains</term><term>Lymphoedème (diagnostic)</term><term>Lymphoedème (étiologie)</term><term>Mâle</term><term>Mélanome ()</term><term>Mélanome (anatomopathologie)</term><term>Noeuds lymphatiques (anatomopathologie)</term><term>Tumeurs cutanées ()</term><term>Tumeurs cutanées (anatomopathologie)</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Biopsy</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Mélanome</term><term>Noeuds lymphatiques</term><term>Tumeurs cutanées</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Melanoma</term><term>Skin Neoplasms</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Biopsie</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Lymph Nodes</term><term>Melanoma</term><term>Skin Neoplasms</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Time Factors</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Facteurs temps</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Mélanome</term><term>Mélanome malin</term><term>Peau</term><term>Biopsie</term><term>Adénopathie</term><term>Complication</term><term>Lymphoedème</term><term>Homme</term><term>Tumeurs cutanées</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Background: Sentinel lymph node (SLN) biopsy has rapidly become the procedure of choice for assessing the lymph node status of patients with 1992 American Joint Committee on Cancer stages I and II melanoma. The procedure was designed to be less invasive and, therefore, less likely to cause complications than a complete lymph node dissection. To our knowledge, this is the first report in the literature documenting extremity lymphedema following SLN biopsy. Observation: We report 5 cases of lymphedema after SLN biopsy in patients being routinely followed up after melanoma surgery at the Massachusetts General Hospital Melanoma Center, Boston. Three cases were mild, and 2 were moderate. Potential contributing causes of lymphedema were present in 4 patients and included the transient formation of hematomas and seromas, obesity, the possibility of occult metastatic melanoma, and the proximal extremity location of the primary melanoma excision. Four of the patients underwent an SLN biopsy at our institution. We used the total number of SLN procedures (N = 235) that we have performed to calculate a 1.7% baseline incidence of lymphedema after SLN biopsy. Conclusions: Sentinel lymph node biopsy can be complicated by mild and moderate degrees of lymphedema, with an incidence of at least 1.7%. Some patients may have contributing causes for lymphedema other than the SLN biopsy, but many of these causes are difficult to modify or avoid.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Massachusetts</li></region><settlement><li>Boston</li></settlement></list><tree><country name="États-Unis"><region name="Massachusetts"><name sortKey="Wrone, D A" sort="Wrone, D A" uniqKey="Wrone D" first="D. A." last="Wrone">D. A. Wrone</name></region><name sortKey="Cosimi, A B" sort="Cosimi, A B" uniqKey="Cosimi A" first="A. B." last="Cosimi">A. B. Cosimi</name><name sortKey="Cosimi, A B" sort="Cosimi, A B" uniqKey="Cosimi A" first="A. B." last="Cosimi">A. B. Cosimi</name><name sortKey="Gadd, M A" sort="Gadd, M A" uniqKey="Gadd M" first="M. A." last="Gadd">M. A. Gadd</name><name sortKey="Gadd, M A" sort="Gadd, M A" uniqKey="Gadd M" first="M. A." last="Gadd">M. A. Gadd</name><name sortKey="Sober, A J" sort="Sober, A J" uniqKey="Sober A" first="A. J." last="Sober">A. J. Sober</name><name sortKey="Sober, A J" sort="Sober, A J" uniqKey="Sober A" first="A. J." last="Sober">A. J. Sober</name><name sortKey="Souba, W W" sort="Souba, W W" uniqKey="Souba W" first="W. W." last="Souba">W. W. Souba</name><name sortKey="Souba, W W" sort="Souba, W W" uniqKey="Souba W" first="W. W." last="Souba">W. W. Souba</name><name sortKey="Tanabe, K K" sort="Tanabe, K K" uniqKey="Tanabe K" first="K. K." last="Tanabe">K. K. Tanabe</name><name sortKey="Tanabe, K K" sort="Tanabe, K K" uniqKey="Tanabe K" first="K. K." last="Tanabe">K. K. Tanabe</name><name sortKey="Wrone, D A" sort="Wrone, D A" uniqKey="Wrone D" first="D. A." last="Wrone">D. A. Wrone</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00A898 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 00A898 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= Pascal:00-0323767
|texte= Lymphedema after Sentinel lymph node biopsy for cutaneous melanoma: A report of 5 cases
}}
| This area was generated with Dilib version V0.6.31. |  |